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httpInﬂammatory cells, ceramides, and expression of
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human abdominal aortic aneurysms
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Background: Abdominal aortic aneurysm (AAA) is a deadly irreversible weakening and distension of the abdominal aortic
wall. The pathogenesis of AAA remains poorly understood. Investigation into the physical and molecular characteristics
of perivascular adipose tissue (PVAT) adjacent to AAA has not been done before and is the purpose of this study.
Methods and Results:Human aortae, periaortic PVAT, and fat surrounding peripheral arteries were collected from patients
undergoing elective surgical repair of AAA. Control aortas were obtained from recently deceased healthy organ donors
with no known arterial disease. Aorta and PVAT was found in AAA to larger extent compared with control aortas.
Immunohistochemistry revealed neutrophils, macrophages, mast cells, and T-cells surrounding necrotic adipocytes. Gene
expression analysis showed that neutrophils, mast cells, and T-cells were found to be increased in PVAT compared with
AAA as well as cathepsin K and S. The concentration of ceramides in PVAT was determined using mass spectrometry and
correlated with content of T-cells in the PVAT.
Conclusions: Our results suggest a role for abnormal necrotic, inﬂamed, proteolytic adipose tissue to the adjacent aneu-
rysmal aortic wall in ongoing vascular damage. (J Vasc Surg 2016;-:1-9.)
Clinical Relevance: Abdominal aortic aneurysm is an inﬂammatory disease. This study shows that adipocytes surrounding
the aorta may be a great source of inﬂammatory leukocytes that are attracted by adipocytes undergoing necrosis and by
proinﬂammatory ceramides. Future strategies preventing the formation of perivascular adipose tissue and targeting
inﬂammation from the adventitial side must be taken into consideration.The prevalence of abdominal aortic aneurysm (AAA)
affects around 2% of the world’s population and has
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://dx.doi.org/10.1016/j.jvs.2015.12.056treatments for this disease other than invasive and costly
procedures to replace or reinforce the dilated aortic
segment.2 The mechanism of pathogenesis of AAA is not
entirely clear yet. Thus, in order to understand this disease
better, a closer investigation of AAA and its surrounding
tissue is necessary.
AAA has been classiﬁed as a vascular matrix degenera-
tive disease3 that causes an enlargement to the abdominal
segment of the aorta. Various proteases capable of degrad-
ing the matrix proteins in the aorta have been found in the
abdominal aorta and its intraluminal thrombus.4-6 Previous
studies depict leukocytes as sources for production of
proteases capable of degrading the aortic wall, thus,
enlargement of the AAA.
In all tissues, recruitment of immune cells or inﬂamma-
tion begins at postcapillary venules.7 Human abdominal
aorta lacks vasa vasorum.8 Facilitated immune cell recruit-
ment, however, occurs through neovascularization that is
frequently seen in adventitia layer of aneurysmal aorta.9,10
Adjacent to the adventitia layer of the aorta, a supporting
tissue of fat depot comprising of a mixture of white and
brown fat shields the vessel against the surrounding tissues.
This perivascular adipose tissue (PVAT) varies in amount
and content in different disorders and is highly vascular-
ized.11 PVAT regulates vascular function by producing a
large number of vasocrine molecules. Excessive accumula-
tion of inﬂamed, dysfunctional PVAT has been proposed
to be a major risk factor for endothelial dysfunction and
atherosclerosis.12,131
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correlates to the quantity of PVAT.14 Further, the quantity
of PVAT could be examined clinically by computer tomog-
raphy and is associated with aneurysmal diameter.15
A growing body of evidence indicates that adipose tissue
functions more than just a storage organ. Adipose tissue
is a dynamic participant in normal physiology and in the
development of several diseases. In particular, PVAT
secretes cytokines and other factors that contribute to
sterile inﬂammation of vessels in atherosclerosis.16 PVAT
has been shown to be responsible for production of
adipokines such as interleukin (IL)-6, which is elevated in
the plasma of AAA patients.17 Surprisingly, the release of
these factors by PVAT has not been investigated in AAA.
Sphingolipid metabolites, particularly ceramide and
sphingosine-1-phosphate (S1P), are signaling molecules
that regulate a diverse range of cellular processes that are
important in immunity, inﬂammation, and inﬂammatory
disorders. It has previously been shown that adipose tissue
is inﬁltrated with macrophages and is a source of ceramides
that can induce inﬂammation.18 Ceramides are fatty acids of
various lengths, and their synthesis is stimulated by long-
chain fatty acids that are readily found in adipocytes.
Mammalian cells generally have ceramides with backbone
of C16 to C26 carbons. Evidence suggests that adipose
tissue inﬂammation and abnormalities in sphingolipid meta-
bolismmay contribute to the metabolic disorders associated
with obesity, and it has been shown that ceramide is impli-
cated in the pathogenesis of obesity and cardiovascular dis-
ease.19,20 Ceramides regulate apoptosis and necrosis; they
activate protein kinases and are capable of inducing cell-
signaling cascades.21 Cytokines such as tumor necrosis
factor (TNF)-a induce inﬂammation through ceramides22
and matrix metalloproteinase (MMP)-2 participate in
production and activation of ceramides.23
The purpose of this study is to elucidate the role of
PVAT in the pathogenesis of AAA by investigating the
composition of PVAT in AAA.METHODS
Sample collection. Patients undergoing elective
surgery at Linköping University Hospital, demonstrating
an aortic diameter >55 mm with computed tomography
scan, were included in the study. No inﬂammatory or
mycotic aneurysm was included. Patients characteristics
are described in the Supplementary Table (online only).
The aneurysmal tissue from the anterior excess sac was
removed in the safest way from 19 patients, and peripheral
arteries of the abdominal wall were taken during the
opening from four patients. Aneurysmal biopsies from pa-
tients were gently divided by surgical adventicectomy un-
der a light microscope into following four parts: (1)
intima/media; (2) adventitia; (3) whole AAA wall without
PVAT; and (4) PVAT surrounding the AAA vessel.
Control infrarenal aortas were obtained from nine
organ donors without clinical or macroscopic signs of
aortic aneurysm or atherosclerosis.All AAA participants gave informed consent to the
study, which was approved by the regional ethical review
board in Linköping, Sweden. The use of organ donors
was approved by the regional ethical review board in
Lund, Sweden.
Angiotensin II-induced murine AAA. Following the
standard procedure as described previously,24 an AAA was
induced in 8-week-old male Apoe/ mice (n ¼ 10),
obtained from Taconic (Ry, Denmark), using the angio-
tensin II model or sodium chloride as control. Operated
animals were monitored daily for any sign of discomfort;
water and chow diet was provided ad libidum throughout
the entire study. Upon 28 days of infusion, mice were
sacriﬁced, and the aorta was removed and ﬁxated in 4% zinc
formaldehyde for histologic analysis. Animal studies were
approved by the local ethical committee (68-14) in
Linköping, Sweden.
Immunohistochemistry. Samples taken from the
operation were ﬁxed in zinc paraformaldehyde overnight
and then transferred to 70% ethanol. Then, samples were
dried in a dehydration machine and embedded in parafﬁn.
Parafﬁn-embedded samples were sectioned in 5-mm-thick
sections, and the slides were incubated in 56C for 4 hours.
Sections from parafﬁn-embedded aortic wall with
PVAT were de-parafﬁnized and hydrated. After epitope
unmasking with DIVA decloaker (Biocare Medical,
Concord, Calif), and then background blocking with Pun-
isher, sections were incubated 1 hour at 25C with primary
antibodies: CD66b (Fitzgerald, Acton, Mass), CD3epsilon
(Bioworld Technology, San Francisco, Calif), CD68 (Leica
Biosystems, Newcastle, United Kingdom), Mast cell tryp-
tase (Dako, Glostrup, Denmark), MMP-9 (Acris, Herford,
Germany), and Perilipin (Acris). All antibodies except Per-
ilipin were of monoclonal type. Then, the slides were rinsed
in tris-buffered saline and incubated with MACH II
alkaline phosphatase (Biocare Medical) for 30 minutes. Af-
ter washing with tris-buffered saline, sections were incu-
bated with Warp red for 5 minutes, then rinsed with
DH2O, followed by hematoxylin counterstaining, and
then dehydrated and mounted with Pertex (Histolab,
Gothenburg, Sweden). For negative controls, we omitted
primary antibody. Alternatively, for the primary antibody,
the slides were incubated with matching secondary anti-
body followed by avidin-biotin conjugating system ABC,
stained with 30-diaminobenzidine, and counterstained as
mentioned above.
Real-time polymerase chain reaction. All samples
were ﬁxed in RNAlater (Ambion, Austin, Tex) for 24 hours
and thereafter stored in 80C for RNA isolation. Aortic
biopsies from nine human controls and nine aneurysmal
tissues including the PVAT were homogenized with Tissue
Lyser using safe-lock tubes with a metal bead and trizol-
chloroform. Total RNA was extracted using RNeasy Mini
kit (Qiagen, Hilden, Germany) and reversely transcribed
with random primers and Superscript III (Invitrogen,
Carlsbad, Calif) according to manufacturer’s instructions.
Quantitative real-time polymerase chain reaction (PCR)
was performed on a 7500 Fast Real-time PCR Sequence
Fig 1. An open repair surgery where aneurysm sack is seen with some perivascular fat covering the enlarged aorta (black
arrows) (A). Microscopic image of perivascular fat (arrow) seen in experimental model of aneurysm (B) and its control
where no perivascular adipose tissue (PVAT) is seen (C). Similar to human abdominal aortic aneurysm (AAA), mouse
models of AAA form PVAT something that is absent in control mice.
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gene expression assay primers and TaqMan Universal Fast
PCR Mastermix (Applied Biosystems) with the following
cycling conditions: 95C for 20 seconds, 40 cycles of 95C
for 3 seconds, and 60C for 30 seconds. Samples were run
in duplicate and semiquantiﬁed against a standard curve.
Results were normalized to human control gene Tbp.
Mass spectrometry. PVAT from AAA (n ¼ 12) and
from peripheral arteries of the abdominal wall from AAA
patients (n ¼ 4) were collected from the same cohort for
analysis of sphingolipid metabolites. Ceramides, sphingo-
sine (SPH), and S1P, were extracted and quantiﬁed as
recently described.25 To the samples, water was added;
the samples were homogenized using a tip sonicator.
Brieﬂy, lipid extraction of tissue fat samples was performed
using C17-ceramide, C17-SPH, and C17-S1P as internal
standards. Sample analysis was carried out by rapid-resolution
liquid chromatography-tandem mass spectrometry using a
quadrupole time-of-ﬂight (QTOF) 6530 mass spectrometer
(Agilent Technologies, Waldbronn, Germany) operating in
the positive electrospray-ionization mode. The precursor
ions of SPH (m/z 300.289), C17-SPH (m/z 286.274),
S1P (m/z 380.256), and C17-S1P (m/z 366.240) were
cleaved into the fragment ions of m/z 282.280, m/z
268.264, m/z 264.270, and m/z 250.252 respectively.
Ceramides (C16-ceramide [m/z 520.508], C17-ceramide
[m/z 534.524], C18-ceramide [m/z 548.540], C18:1-
ceramide [m/z 546.524], C20-ceramide [m/z 576.571],
C22-ceramide [m/z 604.602], C24-ceramide [m/z
632.634], and C24:1-ceramide [m/z 630.618]) were
cleaved into the fragment ion of m/z 264.270. Quantiﬁca-
tion was performed with Mass Hunter Software (Agilent
Technologies).
Statistical analysis. The statistical analysis was
performed with IBM SPSS Statistics v 22 (IBM, Chicago,
Ill). All measurements are represented as median and inter-
quartile range, and P values of <.05 are consideredstatistically signiﬁcant. Two-group comparisons (PVAT vs
control aorta, adventitia and intima/media layer of AAA) of
the quantitative data were performed using the nonpara-
metric Mann-Whitney rank sum test. Pearson correlation
coefﬁcient was calculated to analyze the statistical correla-
tion between ceramide metabolites and leukocyte markers.
RESULTS
AAA is surrounded by abundant PVAT. Fig 1, A
shows a common encounter of vascular surgeons after
exposing the enlarged aorta during vascular repair surgery
of AAA. As it can be seen in this ﬁgure, AAA is surrounded
by PVAT. In agreement with human AAA, presence of
substantial amount of PVAT can also be seen in angio-
tensin II-induced aneurysmal model of AAA (Fig 1, B),
something that is not seen in control aortas in the same
amount (Fig 1, C).
PVAT surrounding AAA contains necrotic
adipocytes and a sterile inﬂammatory inﬁltrate.
Perilipin is a lipid droplet that surrounds adipocytes. Lack
of this protein in fat cells indicates necrosis. We have
identiﬁed necrotic (perilipin negative) adipocytes in
adventitia and PVAT of AAA. Fig 2, A-B shows a serial
section staining experiment of AAA containing PVAT
where presence of necrotic adipocytes is seen. These
necrotic cells appear to be surrounded by neutrophils
(CD66b positive staining) shown in Fig 2, C and macro-
phages (CD68 positive staining) shown in Fig 2, D.
Presence of several other inﬂammatory cells and
proteases were also observed in PVAT of AAA patients. In
Fig 3,A, we showpresence of tryptase positive cells, amarker
for mast cells, and Fig 3, B shows presence of CD3 positive
cells, a marker of T-cells. Fig 3, C shows presence of
MMP-9, themost studied protease in regard to pathogenesis
of AAA. Besides the PVAT, presence of inﬂammatory cells in
the AAA is usually seen in media and adventitia layer of aorta
(data not shown). Nonaneurysmal control aortas have very
Fig 2. Immunohistochemistry. A, Perililpin; B, enlarged perilipin; C, CD66b; and D, CD68. The arrows show 3,30-
diaminobenzidine (DAB) brown positive staining in each image except in (B), which shows perilipin negative necrotic
fat cells.
Fig 3. Presence of mast cell tryptase (A), T-cells (B), and matrix metalloproteinase (MMP)-9 (C) in perivascular
adipose tissue (PVAT; arrows).
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been found in this study (data not shown). Protein data
was conﬁrmed by gene expression analysis. To start with,
we analyzedmessenger RNAmainly expressed by adipocytes
to validate integrity of our PVAT. We found that perilipin
was expressed in greater extent in PVAT as expected
compared with all layers of aneurysmal aortas as well as non-
aneurysmal control aortas (Fig 4,A). In line with this result,
adiponectin, a protein expressed by adipocytes, showed to beexpressed largely by PVAT compared with other samples
(Fig 4, B).
To evaluate vascular inﬁltration of inﬂammatory cells
within the different layers of the vessel wall as well as within
PVAT, gene expression analysis was performed on markers
for immune cells commonly studied with respect to AAA.
Gene expression of the neutrophil marker, CD66b, was
greater in PVAT compared with adventitial layer of the
aneurysmal aorta as well as control aortas (P < .05; Fig 4, F).
Fig 4. Gene expression of perilipin (A), adiponectin (B), CD68 (C), CD3e (D), mast cell chymase (E), and CD66b
(F) from human nonaneurysmal control aortas, abdominal aortic aneurysm (AAA) samples and periaortic fat as
determined by real-time polymerase chain reaction (PCR) (n ¼ 9 in all groups). *P < .05, **P < .01,
***P < .001.Open circle,B ¼Outlier greater than 1.5 times the interquartile range. Filled circle,C ¼Outlier greater
than 3 times the interquartile range. A.adv, Aortic adventitia; A.med, aortic intima/media; PVAT, perivascular adipose
tissue.
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equally expressed in PVAT compared with normal aorta
and adventitia layer of AAA samples (Fig 4, C). Macro-
phages were predominantly found in the intima/media
layer of the aneurysmal vessel otherwise. Gene expression
analysis demonstrated a three-fold increase of the mast
cell marker mast cell chymase in PVAT compared with
the intima/media layer of aneurysmal aortas (P < .01)
and compared with nonaneurysmal control aortas
(P < .01; Fig 4, E). The expression of T-cell marker CD3e
was signiﬁcantly increased in PVAT compared with nona-
neurysmal control aortas (P < .05) and in levels equal to
AAA (Fig 4, D).
In other words, neutrophils and mast cells were the
only cell markers that showed an expression to a higher
extent in PVAT compared with aneurysmal wall.Nevertheless, markers for macrophages and T-cells were
also detected. These results are in line with immunohisto-
chemical observations with over presentation of mast cells
and neutrophils in PVAT, (Fig 3, A-B).
PVAT as a possible source of inﬂammatory
cytokines and proteases. We further analyzed the expres-
sion level of several cytokines and proteases in PVAT that
have been shown to participate in pathogenesis of AAA.
IL-6 was found to be increased in PVAT compared with
intima/media of aneurysmal aortas by four-fold (P < .05)
(Fig 5, A). Cell death is another hallmark of AAA. Gene
expression of caspase 3, a marker of apoptosis, was
increased in the aneurysmal aorta by 30% (P < .05)
compared with nonaneurysmal control aortas but detected
at equal levels in PVAT compared with AAA samples
(Fig 5, B).
Fig 5. Gene expression of interleukin (IL)-6 (A), caspase 3 (B), cathepsin K (C), Cathepsin L (D) and Cathepsin S
(E) from human nonaneurysmal control aortas, abdominal aortic aneurysm (AAA) samples, and periaortic fat as
determined by real-time polymerase chain reaction (PCR) (n ¼ 9 in all groups). *P < .05. Open circle,B ¼ Outlier
greater than 1.5 times the interquartile range. Filled circle,C ¼ Outlier greater than 3 times the interquartile range.
A.adv, Aortic adventitia; A.med, aortic intima/media; PVAT, perivascular adipose tissue.
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L, and S were examined. All three cathepsins were highly
expressed in intima/media of aneurysmal aortas
(Fig 5, C-E). In PVAT, the mRNA expression of cathepsin
K and cathepsin S were also found to be increased by
47% (P < .05) and by 116% (P < .05) compared with
nonaneurysmal control aortas.
To establish a broader protease proﬁle of other signiﬁ-
cant mediators of AAA, gene expression analyses were also
performed on the metalloproteinases MMP-2, MMP-8,
MMP-9, and MMP-12 but also on the proinﬂammatory
cytokine TNF-a (Supplementary Fig, online only).
Sphingolipid metabolite proﬁle in PVAT possible
responsible for inﬁltration of T-cells in AAA. We
considered whether sphingolipid metabolites such as
ceramides could be one of the driving proinﬂammatory fac-
tors associated with leukocyte inﬁltration in PVAT and
AAA and analyzed the ceramide content as well as someof the target molecules important in the biogenesis of
ceramides in PVAT from AAA and peripheral arteries
from AAA patients (Table I). When correlating these
lipids with gene expression of markers for leukocytes in
PVAT, interesting results were observed (Table II).
Markers of macrophages, mast cells, and neutrophils were,
in general, negatively associated with the lipids with few
exceptions. Speciﬁcally, macrophages where strongly
negatively associated with C16-ceramides in PVAT
(r ¼ 0.81; P ¼ .05; Fig 6, A), whereas neutrophils were
negatively associated with C24:1-ceramides in adventitia of
AAA aortas (r ¼ 0.81; P < .05; Fig 6, B) but positively
with S1P in PVAT (r ¼ 0.82; P < .05; Fig 6, C). In
contrast, markers for T-cells were in general positively
associated with the most of the molecules in both PVAT
and adventitia layer of the aorta reaching a signiﬁcant
correlation in adventitia with C16-ceramide of PVAT
(r ¼ 0.91; P < .05; Fig 6, D).
Table II. Correlation (r value) between sphingolipid
content and leukocyte markers in perivascular adipose
tissue (PVAT)
Macrophages Neutrophils
Mast
cells T-cells
Cer16, pmol/mg
protein
0.81 (P ¼ .05) 0.53 0.40 0.46
Cer18, pmol/mg
protein
0.40 0.14 0.63 0.58
Cer20, pmol/mg
protein
0.71 0.59 0.55 0.59
Cer22, pmol/mg
protein
0.72 0.50 0.58 0.34
Cer24, pmol/mg
protein
0.58 0.10 0.36 0.09
Cer24:1, pmol/
mg protein
0.61 0.14 0.33 0.22
Total ceramides,
pmol/mg
protein
0.73 0.36 0.40 0.34
Sphingosine,
pmol/mg
protein
0.66 0.37 0.24 0.02
S1P, pmol/mg
protein
0.58 0.82 (P < .05) 0.13 0.10
ASM, pmol/h/
mg protein
0.74 0.60 0.32 0.42
ASM, Acid sphingomyelinase; S1P, sphingosine-1-phosphate.
Table I. Sphingolipid content in perivascular adipose
tissue (PVAT) and peripheral fat from patients with
abdominal aortic aneurysm (AAA)
PVAT
(n ¼ 12)
Peripheral fat
(n ¼ 4)
Cer16, pmol/mg protein 879 6 947 1435 6 785
Cer18, pmol/mg protein 228 6 360 320 6 103
Cer20, pmol/mg protein 88 6 88 173 6 28
Cer22, pmol/mg protein 316 6 329 588 6 179
Cer24, pmol/mg protein 455 6 434 584 6 175
Cer24:1, pmol/mg protein 850 6 722 1296 6 414
Total ceramides, pmol/mg protein 2816 6 2832 4397 6 464
Sphingosine, pmol/mg protein 69 6 42 80 6 27
S1P, pmol/mg protein 2.2 6 6.4 1.1 6 1.0
ASM, pmol/h/mg protein 11.6 6 7.7 6.7 6 1.2
ASM, Acid sphingomyelinase; S1P, sphingosine-1-phosphate.
No signiﬁcant differences between the groups.
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In this study we characterized the PVAT that accumu-
lates adjacent to human and murine AAA that has been
shown to be correlated to the growth of AAA in diameter.15
We investigated human PVAT by elucidating the content of
necrotic adipocytes, the type of inﬁltrating leukocytes, and
the expression of proteases by immunohistochemistry and
real-time quantitative PCR. Using lipidomics, we have also
established a ceramide proﬁle of PVAT in AAA.
Adipocyte hypertrophy causes local hypoxia that in
turn triggers inﬁltration of leukocytes. PVAT has beenshown to be particularly susceptible to inﬂammation, which
in turn induces vascular dysfunction.7,12,26 Our results
show enhanced presence of inﬂammatory cells in PVAT
of AAA, which is in agreement with what is observed in
PVAT surrounding atherosclerotic aortae.7 Necrotic adipo-
cytes that appear as perilipin-negative cells result in the
recruitment of immune cells.18 We found abundant neu-
trophils, macrophages, mast cells, and T-cells in PVAT
adjacent to AAA and in the near vicinity of necrotic adipose
tissue. This has been shown that abnormal vessel wall of
AAA contains abundant immune cells.5,27 However, high
hemodynamic forces do not allow signiﬁcant leukocyte
rolling, adherence, or diapedesis at the aortic luminal sur-
face. Likely, portals for their entry include capillary neovas-
cularization that frequently develops within the adventitial
layer of AAA as well as via post-capillary venules within
nearby PVAT, followed by migration into the adjacent
aneurysm. We also have made similar observations in
thoracic aortic aneurysm (unpublished data) indicating
that this phenomenon could play a general role in aneu-
rysmal disease.
Leukocytes in PVAT may contribute to the production
of proteases that can further damage the aortic wall. We
found that cathepsin K and cathepsin S are elevated in
PVAT adjacent to AAA compared with their levels in con-
trol aortae. Cathepsin S induces macrophage migration by
degrading elastic ﬁbers,28 and activity of cathepsin K shows
to have a pivotal role in the elastase model of AAA.29 Our
data, however, show that these proteases are highest
expressed by aortic media in AAA, but their presence in
PVAT may speculatively contribute to the pathogenesis
of this disease.
The overwhelming, dominant causal agent in human
AAA is tobacco smoking. PVAT from smokers has been
shown to attract monocytes more avidly than adipocytes
from nonsmokers.30 Cigarette smoke raises the level of
ceramides that promotes sterile inﬂammation.31 Interest-
ingly, ceramide and sphingomyelin, a ceramide metabolite
and precursor, are both independent risk factors of athero-
sclerosis.32,33 Ceramide was shown to be critically involved
in the signal transduction of proinﬂammatory mediators
such as TNF-a and IL-1, in the synthesis of IL-6 and in
the induction of programmed cell death, for instance after
CD95 or DR5 stimulation.34 Interestingly, our data show
that concentration of ceramides we measured in PVAT
correlated positively with the T-cell marker CD3 in the
adventitia of aortic wall of aneurysm but correlated nega-
tively with neutrophils, mast cells, and macrophages. This
suggests that ceramides are not involved in the recruitment
of most of the inﬂammatory cells except for T-cells. Ceram-
ides do not seem to be involved in the induction of necrosis
either, a phenomenon that seems to be responsible for
recruiting the macrophages and neutrophils into the
PVAT. Instead, other factors should be considered and de-
serves attention in further studies. In fact, Guzik et al35
already showed that angiotensin II increases inﬁltration of
T-cells into the PVAT.
Fig 6. Correlations between gene expression and ceramide/enzyme content of perivascular adipose tissue (PVAT).
C16 and CD68 messenger RNA (mRNA) (A), C24:1 and CD66b mRNA (B), S1P and CD66b mRNA (C), and C16
and CD3 mRNA (D) (n ¼ 6).
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of ceramide in the lung of mice results in an increased num-
ber of natural killer T-cells that mediate inﬂammation and
tissue destruction.36 Thus, the primary role of ceramides in
PVAT of AAA remains to be resolved. In addition, whether
the natural killer T-cells are also increased in PVAT of AAA
and play a role in the disease must be resolved.
Apoptosis of cells in the aneurysmal aorta is a hallmark
of AAA,37 a ﬁnding in line with our present data. The
expression of caspase 3 was signiﬁcantly greater in AAA
than in control aorta. In PVAT, however, only a slight
upregulation of caspase 3 compared with that in the control
aorta was observed.
CONCLUSIONS
We have shown that human and murine AAAs accu-
mulate periaortic adipose tissue that is characterized by
adipocyte necrosis, sterile inﬂammation, and robust expres-
sion of proteases. Our results suggest a role for this
abnormal tissue in ongoing damage to the adjacent aneu-
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Supplementary Fig (online only). Gene expression of matrix metalloproteinase (MMP) 2 (A), MMP-8 (B), MMP-9
(C), MMP-12 (D), and tumor necrosis factor (TNF)-a (E) from human nonaneurysmal control aortas, abdominal
aortic aneurysm (AAA) samples, and periaortic fat as determined by real-time polymerase chain reaction (PCR; n ¼ 9 in
all groups). *P < .05 and **P < .01. Open circle,B ¼ Outlier greater than 1.5 times the interquartile range. Filled
circle,C ¼ Outlier greater than 3 times the interquartile range. A.adv, Aortic adventitia; A.med, aortic intima/media;
PVAT, perivascular adipose tissue.
Supplementary Table (online only). Patient
characteristics
Risk factor
Age, years 70 6 5.2
Male/female 16/3
AAA diameter, mm 63 6 12.2
BMI 27 6 3.1
Systolic and diastolic blood
pressure, mm hg
150 6 18.3/90 6 10.0
AAA, Abdominal aortic aneurysm; BMI, body mass index.
JOURNAL OF VASCULAR SURGERY
9.e1 Folkesson et al --- 2016
